Cervidil

   
Google
 
Web NewDrugInformation.com

Cervidil


Drug - Cervidil
The trade name of the product as shown on the labeling.

Dosage - INSERT, EXTENDED RELEASE; VAGINAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Dinoprostone
Multiple ingredients are in alphabetical order.

Strength - 10MG
The potency of the active ingredient(s), Dinoprostone. May repeat for multiple part products.

Applicant - CONTROLLED THERAP
The firm name holding legal responsibility for Cervidil. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020411
The FDA assigned number to Cervidil. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Cervidil. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Mar 30, 1995
The date Cervidil was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Cervidil. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Cervidil is in. Format is RX, OTC, DISCN.

Applicant Full Name - Controlled Therapeutics (scotland) Ltd
The full name of the firm holding legal responsibility for the new application of Cervidil.

Cervidil